Siemens Delivers for the First Time a Biograph mMR to a Private Radiology Practice

Siemens HealthcareThe German private practice MRI, Nuclear Medicine and PET/CT Center Bremen Central ("MRT-, Nuklearmedizin- und PET/CT-Zentrum Bremen Mitte") has commissioned Siemens Healthcare to supply a Biograph mMR. This represents the first use of the system by a private practice for the routine examination of patients. Biograph mMR is the world's first fully integrated whole-body molecular MR with simultaneous magnetic resonance (MR) and positron emission tomography (PET) imaging. The first four systems of this kind have been used to date in university hospitals and research centers with a focus on clinical research. At the group practice in Bremen, nuclear physicians and radiologists will share use of the Biograph mMR system to examine patients quickly and safely for oncological and neurological diseases. A whole-body scan with the molecular MR system can now be completed in approximately 30 minutes, compared with one hour or more for sequential MR and PET examinations.

"The new device heralds a completely new type of diagnosis: The molecular information, in conjunction with Biograph mMR's excellent anatomical and true-to-detail MR imaging, will help us make our diagnoses for patients even better and faster than what is currently possible. The simultaneous acquisition enables the benefits of MRI - such as functional examinations or spectroscopy - to be combined with PET, providing the doctor with additional information which can be used for personalized therapy," said Professor Christiane Franzius, nuclear physician and partner at the practice in Bremen.

"With simultaneous MR and PET images we also expect an improvement in our workflow. The result is a faster examination, which benefits the patient as well. Patient comfort is very important to us," explained Dr. Markus Lentschig, a radiologist and one of the partners at the "Bremen Mitte" practice. "Dose reduction is another major concern of ours - and this can be quite considerable compared to an examination with a PET/CT (computed tomography) device. This is particularly critical in the examination of children and young adults, also with regard to the sometimes numerous follow-up examinations for therapy monitoring. We will be using this innovative system for many neurological, cardiac and, especially, oncological diseases."

Since November 2010, several Biograph mMR systems have been installed at institutions in Europe and the USA. By allowing simultaneous acquisition and visualization of MR and PET data, this innovative system opens up new possibilities in disease detection in the fields of neurology, oncology, and cardiology.

The Bremen practice currently uses three Siemens MRI devices: The 3 Tesla Magnetom Verio system and the Magnetom Espree and Magnetom Avanto, both 1.5T systems. A new Magnetom Skyra 3T MRI system will be installed at the same time as the Biograph mMR.

Related news articles:

About Siemens Healthcare
The Siemens Healthcare Sector is one of the world's largest healthcare solution providers and a leading manufacturer and service provider in the fields of medical imaging, laboratory diagnostics, hospital information technology and hearing instruments. It offers solutions covering the entire supply chain under one roof - from prevention and early detection to diagnosis and on to treatment and aftercare. By optimizing clinical workflows oriented toward the most important clinical pictures, Siemens also strives to make healthcare faster, better and, at the same time, less expensive. Siemens Healthcare currently has some 48,000 employees worldwide and is present throughout the world. During fiscal 2010 (up to September 30) the Sector posted sales worth 12.4 billion euros and profits of around 750 million euros.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...